Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 22 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapyBraunlin, E.; Rosenfeld, H.; Kampmann, C.; Johnson, J.; Beck, M.; Giugliani, R.; Guffon, N.; Ketteridge, D.; Miranda, C.; Scarpa, M.; Schwartz, I.; Teles, E.; Wraith, J.; Barrios, P.; Dias da Silva, E.; Kurio, G.; Richardson, M.; Gildengorin, G.; Hopwood, J.; Imperiale, M.; et al.
2005Laronidase treatment of mucopolysaccharidosis IWraith, J.; Hopwood, J.; Fuller, M.; Meikle, P.; Brooks, D.
2005Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I/II studyHarmatz, P.; Kramer, W.; Hopwood, J.; Simon, J.; Butensky, E.; Swiedler, S.
1996Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patientsLitjens, T.; Brooks, D.; Peters, C.; Gibson, G.; Hopwood, J.
2008Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfataseHarmatz, P.; Giugliani, R.; Schwartz, I.; Guffon, N.; Teles, E.; Miranda, C.; Wraith, J.; Beck, M.; Arash, L.; Scarpa, M.; Ketteridge, D.; Hopwood, J.; Plecko, B.; Steiner, R.; Whitley, C.; Kaplan, P.; Yu, Z.; Swiedler, S.; Decker, C.
2015Butanolysis derivatization: improved sensitivity in LC-MS/MS quantitation of heparan sulfate in urine from mucopolysaccharidosis patientsTrim, P.; Hopwood, J.; Snel, M.
1997Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristicsJones, M.; Alroy, J.; Rutledge, J.; Taylor, J.; Alvord Jnr., E.; Toone, J.; Applegarth, D.; Hopwood, J.; Skutelsky, E.; Ianelli, C.; Thorley Lawson, D.; Mitchell Herpolsheimer, C.; Arias, A.; Sharp, P.; Evans, W.; Sillence, D.; Cavanagh, K.
2002Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: Implications for the prediction of disease severityWhitfield, P.; Nelson, P.; Sharp, P.; Bindloss, C.; Dean, C.; Ravenscroft, E.; Fong, B.; Fietz, M.; Hopwood, J.; Meikle, P.
2001Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patientsPerkins, K.; Muller, V.; Weber, B.; Hopwood, J.
2000Saposins A,B,C, and D in plasma of patients with lysosomal storage disordersChang, M.; Bindloss, C.; Grabowski, G.; Qi, X.; Winchester, B.; Hopwood, J.; Meikle, P.